Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.02M Sell
21,155
-626
-3% -$32K 0.03% 578
2026
Q2
$1.14M Sell
21,781
-932
-4% -$49.3K 0.03% 550
2026
Q1
$1.25M Sell
22,713
-9,806
-30% -$531K 0.03% 484
2025
Q4
$1.59M Buy
32,519
+644
+2% +$30K 0.04% 380
2025
Q3
$1.38M Sell
31,875
-1,014
-3% -$39.6K 0.04% 425
2025
Q2
$1.26M Sell
32,889
-3,527
-10% -$135K 0.04% 429
2025
Q1
$1.41M Buy
36,416
+1,597
+5% +$58.5K 0.05% 375
2024
Q4
$1.18M Buy
34,819
+630
+2% +$22.7K 0.04% 438
2024
Q3
$1.4M Sell
34,189
-6,074
-15% -$248K 0.04% 390
2024
Q2
$1.55M Sell
40,263
-13,513
-25% -$568K 0.05% 354
2024
Q1
$2.31M Buy
53,776
+27,528
+105% +$1.14M 0.07% 273
2023
Q4
$973K Sell
26,248
-34,600
-57% -$1.24M 0.08% 275
2023
Q3
$2.21M Buy
60,848
+457
+0.8% +$16.2K 0.08% 256
2023
Q2
$2.15M Sell
60,391
-5,440
-8% -$195K 0.08% 267
2023
Q1
$2.34M Buy
65,831
+2,164
+3% +$75.7K 0.08% 261
2022
Q4
$2.24M Buy
63,667
+11,802
+23% +$393K 0.08% 261
2022
Q3
$1.53M Buy
51,865
+7,305
+16% +$277K 0.06% 324
2022
Q2
$2.42M Buy
44,560
+4,761
+12% +$263K 0.08% 235
2022
Q1
$2.17M Sell
39,799
-316
-0.8% -$17.2K 0.06% 294
2021
Q4
$2.21M Sell
40,115
-3,269
-8% -$170K 0.06% 306
2021
Q3
$2.07M Sell
43,384
-392
-0.9% -$19.7K 0.06% 321
2021
Q2
$2.18M Buy
43,776
+2,733
+7% +$131K 0.06% 312
2021
Q1
$1.83M Buy
41,043
+6,145
+18% +$279K 0.06% 333
2020
Q4
$1.6M Sell
34,898
-3,151
-8% -$145K 0.05% 321
2020
Q3
$1.79M Buy
38,049
+3,102
+9% +$155K 0.07% 262
2020
Q2
$1.78M Buy
34,947
+140
+0.4% +$7.18K 0.08% 259
2020
Q1
$1.65M Buy
34,807
+6,564
+23% +$350K 0.1% 210
2019
Q4
$1.66M Buy
28,243
+2,407
+9% +$134K 0.07% 289
2019
Q3
$1.38M Buy
25,836
+164
+0.6% +$8.44K 0.07% 299
2019
Q2
$1.28M Buy
25,672
+200
+0.8% +$10K 0.07% 294
2019
Q1
$1.33M Buy
25,472
+1,574
+7% +$78.7K 0.08% 262
2018
Q4
$1.14M Sell
23,898
-235
-1% -$11.6K 0.08% 236
2018
Q3
$1.21M Sell
24,133
-1,217
-5% -$61.8K 0.07% 263
2018
Q2
$1.28M Sell
25,350
-764
-3% -$38.5K 0.09% 234
2018
Q1
$1.28M Sell
26,114
-5,703
-18% -$266K 0.09% 227
2017
Q4
$1.41M Sell
31,817
-2,127
-6% -$98.3K 0.11% 213
2017
Q3
$1.72M Buy
33,944
+552
+2% +$28K 0.14% 173
2017
Q2
$1.8M Sell
33,392
-554
-2% -$29.5K 0.17% 155
2017
Q1
$1.79M Sell
33,946
-2,655
-7% -$135K 0.17% 147
2016
Q4
$1.76M Buy
36,601
+13,623
+59% +$673K 0.19% 129
2016
Q3
$1.24M Sell
22,978
-1,516
-6% -$83.1K 0.15% 165
2016
Q2
$1.33M Buy
24,494
+630
+3% +$33.2K 0.17% 146
2016
Q1
$1.21M Buy
23,864
+624
+3% +$31.1K 0.17% 142
2015
Q4
$1.17M Buy
23,240
+2,006
+9% +$102K 0.16% 144
2015
Q3
$1.02M Buy
21,234
+2,278
+12% +$119K 0.16% 152
2015
Q2
$987K Buy
18,956
+3,012
+19% +$170K 0.14% 185
2015
Q1
$920K Sell
15,944
-91
-0.6% -$5.22K 0.12% 207
2014
Q4
$857K Buy
+16,035
New +$897K 0.11% 217

Other funds holding GSK

Sigma Planning's GSK Position: Q3 2026 in Review

Sigma Planning reduced its GSK (GSK) stake by 2.9% in Q3 2026, selling an estimated $32K and leaving 21,155 shares worth $1.02M. The position accounts for 0.03% of the portfolio, ranked #578.

Sigma Planning first reported a position in GSK in Q4 2014 and has held it in 48 quarters since. The position peaked at $2.42M in Q2 2022. 854 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Sigma Planning held 21,155 shares of GSK worth $1.02M as of Q3 2026.
  • Sigma Planning sold 626 GSK shares in Q3 2026, an estimated $32K.
  • GSK made up 0.03% of Sigma Planning's portfolio in Q3 2026, its #578 holding.
  • Sigma Planning first reported a position in GSK in Q4 2014 and has held it in 48 quarters since.
  • Sigma Planning's GSK position peaked at $2.42M in Q2 2022.
  • 854 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.